10 IPOs entered the public market this past week headlined by Airbnb (ABNB) and DoorDash (DASH), which completed the largest and second-largest IPOs of 2020, respectively. They were joined by 20 blank check IPOs in the...read more
Certara, which provides biosimulation software and services used for drug development, raised $668 million by offering 29.1 million shares (50% primary) at $23, above the range of $19 to $22. The company originally filed to offer 24.4 million shares (58%...read more
Updated Monday, 12/7.
The unicorn IPO parade is set to begin in the week ahead, with DoorDash (DASH) and Airbnb (ABNB) leading the way. A total of nine IPOs and two SPACs are scheduled to raise $7.8 billion.
...read more
Certara, which provides biosimulation software and services used for drug development, announced terms for its IPO on Thursday.
The Princeton, NJ-based company plans to raise $500 million by offering 24.4 million shares (40% insider) at a price range of $19...read more
US IPO Weekly Recap: Airbnb and DoorDash make their public debuts in a 10 IPO week
10 IPOs entered the public market this past week headlined by Airbnb (ABNB) and DoorDash (DASH), which completed the largest and second-largest IPOs of 2020, respectively. They were joined by 20 blank check IPOs in the...read more
Biosimulation company Certara prices upsized IPO above the range at $23
Certara, which provides biosimulation software and services used for drug development, raised $668 million by offering 29.1 million shares (50% primary) at $23, above the range of $19 to $22. The company originally filed to offer 24.4 million shares (58%...read more
US IPO Week Ahead: DoorDash and Airbnb kick off the unicorn parade in a 9 IPO week
Updated Monday, 12/7. The unicorn IPO parade is set to begin in the week ahead, with DoorDash (DASH) and Airbnb (ABNB) leading the way. A total of nine IPOs and two SPACs are scheduled to raise $7.8 billion. ...read more
Biosimulation software company Certara sets terms for $500 million IPO
Certara, which provides biosimulation software and services used for drug development, announced terms for its IPO on Thursday. The Princeton, NJ-based company plans to raise $500 million by offering 24.4 million shares (40% insider) at a price range of $19...read more